Regional and Temporal Variations in the Prevalence of HCV among Hemodialysis Patients in Saudi Arabia
Mohamed Shoukri1,3, Mohamed Al Sebayel2,3, Faisal Abaalkhail2, Hany Elbeshbeshy2, Mohamed Abdelfatah2, Waleed Al-Hamoudi4, Ahmed Elgohary4, Abdelrahman Housawi4, Futwan Al-Mohanna4 and Hussien Elsiesy2,3*
- Corresponding Author:
- Hussien Elsiesy
Al-Faisal University College of Medicine
P.O. Box 3354, Riyadh, Saudi Arabia 11211
E-mail: [email protected]
Received Date: March 03, 2016 Accepted Date: March 29, 2016 Published Date: April 06, 2016
Citation: Shoukri M, Sebayel MA, Abaalkhail F, Elbeshbeshy H, Abdelfatah M, et al (2016) Regional and Temporal Variations in the Prevalence of HCV among Hemodialysis Patients in Saudi Arabia. Epidemiology (Sunnyvale) 6:235. doi:10.4172/2161-1165.1000235
Copyright: © 2016 Shoukri M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Hepatitis C infection among Hemodialysis (HD) patients is a recognized global problem. The incidence and prevalence of HCV in dialysis patients vary widely among geographical regions in the Kingdom of Saudi Arabia (KSA). However, the HCV incidence has marked decline in all regions within KSA. But it is noted that the risk of occasional nosocomial transmission remains. We intend to apply the Seemingly Unrelated Regression (SUR) models to develop a scientific strategy to estimate the future burden of HCV in dialysis units. These predictions may provide baseline information for disease management intervention and cost control. The model based predictions show that the decline in the HCV incidence which started in 2004 is projected to potentially reach zero by the year 2014.